Share
324 Posts.
lightbulb Created with Sketch. 160
clock Created with Sketch. 05/09/22
12:30
Share
Originally posted by Taurean7
↑
Apart from the IPO the RAP BOD has always elected to raise cash through a placement rather than via a CR to retail investors. The advantages are that a placement can raise funds quickly whereas a SPP takes a minimum of a couple of weeks with an unpredictable level of uptake that possibly could require underwriting.The BOD has stated that if the Scheme is defeated it believes it can raise required funds promptly via a placement, with 15% share issuance available without prior need for shareholder consent. The obvious candidate for a rapid placement is Pfizer, who has declared its willingness to purchase RAP shares at 20.8 cents each.
Expand
If this fails, even if Pfizer is going to only own 1% of our shares, RAP will go way above 21c. Considering RAP is still doing R&D with Pfzier, is Pfzier really going to go away?
